FBLG
FibroBiologics, Inc.
Company overview
- Market capitalization
- $9.06M
- Employees
- 15
- Latest publication
- 2026-09-29
About FibroBiologics, Inc.
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Financial statements
Income Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 832,000USD | 573,000USD | 437,000USD | 94,000USD | — | — |
| Gross Profit | -832,000USD | -573,000USD | -437,000USD | -94,000USD | — | — |
| Research Development | 7,407,000USD | 4,504,000USD | 2,368,000USD | 1,147,000USD | 521,000USD | 669,000USD |
| Selling General Administrative | 9,242,000USD | 9,233,000USD | 6,521,000USD | 3,320,000USD | 1,057,000USD | 500,000USD |
| Total Operating Expenses | 15,817,000USD | 13,737,000USD | 8,889,000USD | 4,467,000USD | 1,578,000USD | 1,169,000USD |
| Operating Income | -16,649,000USD | -13,737,000USD | -8,889,000USD | -4,467,000USD | -1,578,000USD | -1,169,000USD |
| Interest Income | 247,000USD | 251,000USD | 0USD | — | — | — |
| Interest Expense | 204,000USD | 20,000USD | 147,000USD | 654,000USD | 4,000USD | — |
| Net Interest Income | 43,000USD | 231,000USD | -147,000USD | -654,000USD | -4,000USD | — |
| Income Before Tax | -18,646,000USD | -11,161,000USD | -16,485,000USD | -5,121,000USD | -1,582,000USD | -1,169,000USD |
| Net Income | -18,646,000USD | -11,161,000USD | -16,485,000USD | -5,121,000USD | -1,582,000USD | -1,169,000USD |
| Net Income From Continuing Ops | -18,646,000USD | -11,161,000USD | -16,485,000USD | -5,121,000USD | -1,582,000USD | — |
| Ebit | -18,442,000USD | -11,141,000USD | -16,338,000USD | -4,467,000USD | — | — |
| Ebitda | -17,610,000USD | -10,568,000USD | -15,901,000USD | -4,373,000USD | -1,578,000USD | — |
| Depreciation And Amortization | 832,000USD | 573,000USD | 437,000USD | 94,000USD | — | 1,169,000USD |
| Reconciled Depreciation | 832,000USD | 573,000USD | 437,000USD | 94,000USD | 0USD | — |
| Total Other Income Expense Net | -1,997,000USD | 2,576,000USD | -7,596,000USD | -654,000USD | -4,000USD | — |
| Selling And Marketing Expenses | — | — | 685,000USD | 94,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 554,000USD | 0USD | 0USD |
| Research Development | 2,953,000USD | 797,000USD | 2,789,000USD | 2,041,000USD | 1,780,000USD | 1,356,000USD | 1,213,000USD | 975,000USD |
| Selling General Administrative | 2,115,000USD | 1,793,000USD | 2,249,000USD | 2,449,000USD | 2,751,000USD | 2,356,000USD | 2,139,000USD | 2,249,000USD |
| Total Operating Expenses | 5,068,000USD | 2,356,000USD | 5,038,000USD | 4,490,000USD | 4,531,000USD | 3,712,000USD | 3,352,000USD | 3,224,000USD |
| Operating Income | -5,068,000USD | -2,590,000USD | -5,038,000USD | -4,490,000USD | -4,531,000USD | -3,712,000USD | -3,352,000USD | -3,224,000USD |
| Interest Income | 20,000USD | 25,000USD | 73,000USD | 50,000USD | 99,000USD | 63,000USD | 79,000USD | 70,000USD |
| Interest Expense | 4,000USD | 204,000USD | 0USD | 0USD | 0USD | 6,000USD | 5,000USD | 5,000USD |
| Net Interest Income | 16,000USD | -179,000USD | 73,000USD | 50,000USD | 99,000USD | 57,000USD | 74,000USD | 65,000USD |
| Income Before Tax | -5,000,000USD | -3,244,000USD | -5,778,000USD | -4,658,000USD | -4,966,000USD | -3,099,000USD | -500,000USD | 898,000USD |
| Net Income | -5,000,000USD | -3,244,000USD | -5,778,000USD | -4,658,000USD | -4,966,000USD | -3,099,000USD | -500,000USD | 898,000USD |
| Net Income From Continuing Ops | -5,000,000USD | -3,244,000USD | -5,778,000USD | -4,658,000USD | -4,966,000USD | -3,099,000USD | -500,000USD | 898,000USD |
| Ebit | -4,996,000USD | -3,040,000USD | -5,778,000USD | -4,658,000USD | -4,966,000USD | -3,093,000USD | -495,000USD | 903,000USD |
| Ebitda | -4,759,000USD | -2,806,000USD | -5,547,000USD | -4,452,000USD | -4,805,000USD | -2,940,000USD | -352,000USD | 1,043,000USD |
| Depreciation And Amortization | 237,000USD | 234,000USD | 231,000USD | 206,000USD | 161,000USD | 153,000USD | 143,000USD | 140,000USD |
| Reconciled Depreciation | 237,000USD | 234,000USD | 231,000USD | 206,000USD | 161,000USD | 153,000USD | 143,000USD | 140,000USD |
| Total Other Income Expense Net | 68,000USD | -654,000USD | -740,000USD | -168,000USD | -435,000USD | 613,000USD | 2,852,000USD | 4,122,000USD |
| Cost Of Revenue | — | 234,000USD | 231,000USD | 206,000USD | — | 153,000USD | — | 140,000USD |
| Gross Profit | — | -234,000USD | -231,000USD | -206,000USD | — | 277,000USD | — | -140,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 103,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 7,929,000USD | 5,938,000USD | 8,744,000USD | 13,907,000USD | 11,426,000USD | 16,445,000USD | 10,469,000USD | 8,912,000USD |
| Cash And Equivalents | 3,515,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 5,850,000USD | 2,905,000USD | 5,240,000USD | 10,178,000USD | 9,327,000USD | 14,228,000USD | 8,198,000USD | 6,509,000USD |
| Total Liabilities | 3,293,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,213,000USD | 1,829,000USD | 6,722,000USD | 10,964,000USD | 8,211,000USD | 12,726,000USD | 6,677,000USD | 10,132,000USD |
| Total Stockholder Equity | 4,636,000USD | 2,600,000USD | 125,000USD | 860,000USD | 2,350,000USD | 2,735,000USD | 2,737,000USD | -2,387,000USD |
| Total Equity Including Noncontrolling Interest | 4,636,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 2,031,000USD | 2,985,000USD | 3,456,000USD | 3,681,000USD | 2,099,000USD | 2,217,000USD | 2,271,000USD | 2,403,000USD |
| Accounts Payable | 1,821,000USD | 850,000USD | 1,069,000USD | 1,801,000USD | 1,417,000USD | 2,697,000USD | 1,179,000USD | 1,208,000USD |
| Short Term Debt | 124,000USD | 969,000USD | 5,216,000USD | 8,693,000USD | 6,251,000USD | 9,569,000USD | 507,000USD | 669,000USD |
| Common Stock | 1,000USD | 1,000USD | — | — | — | — | — | — |
| Retained Earnings | -63,281,000USD | -59,164,000USD | -50,920,000USD | -45,142,000USD | -40,484,000USD | -35,518,000USD | -32,419,000USD | -31,919,000USD |
| Other Current Assets | — | 1,423,000USD | 373,000USD | 1,333,000USD | 660,000USD | 243,000USD | 371,000USD | 536,000USD |
| Total Liab | — | 3,338,000USD | 8,619,000USD | 13,047,000USD | 9,076,000USD | 13,710,000USD | 7,732,000USD | 11,299,000USD |
| Other Current Liab | — | 10,000USD | 437,000USD | 470,000USD | 543,000USD | 460,000USD | 4,991,000USD | 8,255,000USD |
| Capital Stock | — | 1,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cash | — | 1,482,000USD | 4,867,000USD | 8,845,000USD | 8,667,000USD | 13,985,000USD | 7,827,000USD | 5,973,000USD |
| Cash And Short Term Investments | — | 1,482,000USD | 4,867,000USD | 8,845,000USD | 8,667,000USD | 13,985,000USD | 7,827,000USD | 5,973,000USD |
| Net Debt | — | 996,000USD | 2,246,000USD | 1,931,000USD | -1,551,000USD | -3,432,000USD | -6,265,000USD | -4,137,000USD |
| Short Long Term Debt | — | 246,000USD | 4,573,000USD | 8,066,000USD | 5,839,000USD | 9,168,000USD | 115,000USD | 287,000USD |
| Short Long Term Debt Total | — | 2,478,000USD | 7,113,000USD | 10,776,000USD | 7,116,000USD | 10,553,000USD | 1,562,000USD | 1,836,000USD |
| Property Plant Equipment Gross | — | 3,499,000USD | 3,838,000USD | 3,998,000USD | 2,356,000USD | 2,421,000USD | 2,428,000USD | 2,522,000USD |
| Common Stock Shares Outstanding | — | 2,233,026shares | 2,153,627shares | 1,931,763shares | 1,833,656shares | 1,738,705shares | 1,675,833shares | 1,635,956shares |
| Non Current Assets Total | — | 3,033,000USD | 3,504,000USD | 3,729,000USD | 2,099,000USD | 2,217,000USD | 2,271,000USD | 2,403,000USD |
| Non Current Liabilities Total | — | 1,509,000USD | 1,897,000USD | 2,083,000USD | 865,000USD | 984,000USD | 1,055,000USD | 1,167,000USD |
| Non Currrent Assets Other | — | 48,000USD | 48,000USD | 48,000USD | — | — | — | — |
| Net Working Capital | — | 1,076,000USD | -1,482,000USD | -786,000USD | 1,116,000USD | 1,502,000USD | 1,521,000USD | -3,623,000USD |
| Unclassified Non Current Liabilities | — | 1,509,000USD | 1,897,000USD | 2,083,000USD | — | — | 1,055,000USD | 1,167,000USD |
| Unclassified Equity | — | 61,762,000USD | 51,045,000USD | 46,002,000USD | 42,834,000USD | 38,253,000USD | 35,156,000USD | 29,532,000USD |
| Unclassified Current Liabilities | — | — | -4,573,000USD | -8,066,000USD | -5,839,000USD | -9,168,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 9,619,000USD | 16,445,000USD | 11,821,000USD | 4,824,000USD | 468,000USD | — |
| Other Current Assets | 1,455,000USD | 243,000USD | 52,000USD | 59,000USD | 61,000USD | — |
| Total Liab | 3,463,000USD | 13,710,000USD | 10,568,000USD | 8,820,000USD | 1,758,000USD | — |
| Total Stockholder Equity | 6,156,000USD | 2,735,000USD | 1,253,000USD | -3,996,000USD | -1,290,000USD | — |
| Other Current Liab | 108,000USD | 460,000USD | 7,377,000USD | 803,000USD | 229,000USD | — |
| Common Stock | 1,000USD | — | 1,000USD | 1,000USD | — | 1,169,000USD |
| Capital Stock | 1,000USD | 0USD | 1,000USD | 1,000USD | 0USD | — |
| Retained Earnings | -54,164,000USD | -35,518,000USD | -24,357,000USD | -7,872,000USD | -2,751,000USD | -1,169,000USD |
| Cash | 4,894,000USD | 13,985,000USD | 9,163,000USD | 2,266,000USD | 407,000USD | — |
| Cash And Short Term Investments | 4,894,000USD | 13,985,000USD | 9,163,000USD | 2,266,000USD | 407,000USD | — |
| Total Current Assets | 6,349,000USD | 14,228,000USD | 9,215,000USD | 2,625,000USD | 468,000USD | — |
| Total Current Liabilities | 1,759,000USD | 12,726,000USD | 9,183,000USD | 7,073,000USD | 1,758,000USD | — |
| Net Debt | -2,484,000USD | -3,432,000USD | -7,416,000USD | 5,258,000USD | 893,000USD | — |
| Short Term Debt | 706,000USD | 9,569,000USD | 724,000USD | 5,777,000USD | 1,300,000USD | — |
| Short Long Term Debt Total | 2,410,000USD | 10,553,000USD | 1,747,000USD | 7,524,000USD | 1,300,000USD | — |
| Accounts Payable | 945,000USD | 2,697,000USD | 1,444,000USD | 493,000USD | 233,000USD | — |
| Property Plant Equipment Net | 3,222,000USD | 2,217,000USD | 2,606,000USD | 2,199,000USD | 0USD | — |
| Property Plant Equipment Gross | 3,670,000USD | 2,421,000USD | 2,653,000USD | 2,199,000USD | 0USD | — |
| Common Stock Shares Outstanding | 2,233,026shares | 1,643,754shares | 1,624,603shares | 1,623,860shares | 1,623,860shares | 1,624,603shares |
| Non Current Assets Total | 3,270,000USD | 2,217,000USD | 2,606,000USD | 2,199,000USD | 0USD | — |
| Non Current Liabilities Total | 1,704,000USD | 984,000USD | 1,385,000USD | 1,747,000USD | 0USD | — |
| Non Currrent Assets Other | 48,000USD | — | — | — | — | — |
| Net Working Capital | 4,590,000USD | 1,502,000USD | 32,000USD | -4,448,000USD | -1,290,000USD | — |
| Unclassified Non Current Liabilities | 1,704,000USD | — | 1,384,000USD | 1,747,000USD | — | — |
| Unclassified Equity | 60,318,000USD | 38,253,000USD | 25,608,000USD | 2,413,000USD | — | — |
| Short Long Term Debt | — | 9,168,000USD | — | 5,451,000USD | 1,300,000USD | — |
| Unclassified Current Liabilities | — | -9,168,000USD | — | -5,451,000USD | -1,304,000USD | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | 1,461,000USD | 1,461,000USD | — |
| Non Current Liabilities Other | — | — | 1,000USD | — | — | — |
| Net Receivables | — | — | — | 300,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|---|
| Net Income | -18,646,000USD | -11,161,000USD | -16,485,000USD | -5,121,000USD | -1,582,000USD | -1,169,000USD |
| Depreciation | 832,000USD | 573,000USD | 437,000USD | 94,000USD | 0USD | — |
| Stock Based Compensation | 2,686,000USD | 2,219,000USD | 1,765,000USD | 265,000USD | 0USD | — |
| Other Non Cash Items | 2,046,000USD | -4,091,000USD | 7,389,000USD | 389,000USD | 233,000USD | — |
| Change In Working Capital | -3,312,000USD | 559,000USD | 493,000USD | 307,000USD | 172,000USD | — |
| Total Cash From Operating Activities | -16,394,000USD | -11,901,000USD | -6,401,000USD | -4,066,000USD | -1,410,000USD | -1,169,000USD |
| Capital Expenditures | -262,000USD | -184,000USD | -495,000USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -16,656,000USD | -12,085,000USD | -6,896,000USD | -4,066,000USD | -1,410,000USD | -1,169,000USD |
| Total Cashflows From Investing Activities | -262,000USD | -184,000USD | -495,000USD | — | — | — |
| Net Borrowings | 975,000USD | 9,400,000USD | 300,000USD | 3,775,000USD | 1,525,000USD | — |
| Total Cash From Financing Activities | 7,565,000USD | 16,907,000USD | 13,793,000USD | 5,925,000USD | 1,817,000USD | 1,169,000USD |
| Issuance Of Capital Stock | 6,590,000USD | 7,507,000USD | 16,138,000USD | 2,150,000USD | 0USD | — |
| Change In Cash | -9,091,000USD | 4,822,000USD | 6,897,000USD | 1,859,000USD | 407,000USD | — |
| Begin Period Cash Flow | 13,985,000USD | 9,163,000USD | 2,266,000USD | 407,000USD | 0USD | — |
| End Period Cash Flow | 4,894,000USD | 13,985,000USD | 9,163,000USD | 2,266,000USD | 407,000USD | — |
| Investments | — | -184,000USD | -495,000USD | 0USD | — | — |
| Other Cashflows From Financing Activities | — | 9,400,000USD | 13,493,000USD | 2,150,000USD | 292,000USD | 1,169,000USD |
| Unclassified Financing Cash Flow | — | -9,400,000USD | -16,138,000USD | -2,150,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,000,000USD | -3,244,000USD | -5,778,000USD | -4,658,000USD | -4,966,000USD | -3,099,000USD | -500,000USD | 898,000USD |
| Depreciation | 237,000USD | 234,000USD | 231,000USD | 206,000USD | 161,000USD | 153,000USD | 143,000USD | 140,000USD |
| Stock Based Compensation | 694,000USD | 702,000USD | 704,000USD | 729,000USD | 551,000USD | 544,000USD | 571,000USD | 578,000USD |
| Other Non Cash Items | -54,000USD | 481,000USD | 813,000USD | 218,000USD | 534,000USD | -392,000USD | -2,776,000USD | -4,026,000USD |
| Change In Working Capital | -241,000USD | -1,336,000USD | 58,000USD | -479,000USD | -1,555,000USD | -279,000USD | -44,000USD | 463,000USD |
| Total Cash From Operating Activities | -4,364,000USD | -3,163,000USD | -3,972,000USD | -3,984,000USD | -5,275,000USD | -3,073,000USD | -2,606,000USD | -1,947,000USD |
| Capital Expenditures | 0USD | 0USD | -6,000USD | -213,000USD | -43,000USD | -99,000USD | -11,000USD | -66,000USD |
| Free Cash Flow | -4,364,000USD | -3,163,000USD | -3,978,000USD | -4,197,000USD | -5,318,000USD | -3,172,000USD | -2,617,000USD | -2,013,000USD |
| Net Borrowings | 246,000USD | -3,400,000USD | 0USD | 4,375,000USD | 0USD | 9,285,000USD | -172,000USD | — |
| Total Cash From Financing Activities | 952,000USD | 3,190,000USD | 0USD | 4,375,000USD | 0USD | 9,330,000USD | 4,471,000USD | -172,000USD |
| Issuance Of Capital Stock | 706,000USD | 6,590,000USD | 0USD | 0USD | 0USD | 45,000USD | 4,643,000USD | 0USD |
| Change In Cash | -3,412,000USD | 27,000USD | -3,978,000USD | 178,000USD | -5,318,000USD | 6,158,000USD | 1,854,000USD | -2,185,000USD |
| Begin Period Cash Flow | 4,894,000USD | 4,867,000USD | 8,845,000USD | 8,667,000USD | 13,985,000USD | 7,827,000USD | 5,973,000USD | 8,158,000USD |
| End Period Cash Flow | 1,482,000USD | 4,894,000USD | 4,867,000USD | 8,845,000USD | 8,667,000USD | 13,985,000USD | 7,827,000USD | 5,973,000USD |
| Other Cashflows From Financing Activities | 952,000USD | 3,190,000USD | — | 4,375,000USD | — | — | -11,000USD | -172,000USD |
| Unclassified Financing Cash Flow | — | -3,190,000USD | — | -4,375,000USD | — | — | — | — |
| Investments | — | — | -6,000USD | -213,000USD | -43,000USD | -99,000USD | -11,000USD | -66,000USD |
| Total Cashflows From Investing Activities | — | — | -6,000USD | -213,000USD | -43,000USD | -99,000USD | -11,000USD | -66,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.